BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Qiu L, Xu H, Ji M, Shang D, Lu Z, Wu Y, Tu Z, Liu H. Circular RNAs in hepatocellular carcinoma: Biomarkers, functions and mechanisms. Life Sci 2019;231:116660. [PMID: 31319086 DOI: 10.1016/j.lfs.2019.116660] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 11.7] [Reference Citation Analysis]
Number Citing Articles
1 Duan S, Wang S, Huang T, Wang J, Yuan X. circRNAs: Insight Into Their Role in Tumor-Associated Macrophages. Front Oncol 2021;11:780744. [DOI: 10.3389/fonc.2021.780744] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Chen S, Chen C, Hu Y, Song G, Shen X. The diverse roles of circular RNAs in pancreatic cancer. Pharmacol Ther 2021;226:107869. [PMID: 33895187 DOI: 10.1016/j.pharmthera.2021.107869] [Reference Citation Analysis]
3 Lou J, Zhang H, Xu J, Ren T, Huang Y, Tang X, Guo W. circUSP34 accelerates osteosarcoma malignant progression by sponging miR-16-5p. Cancer Sci 2021. [PMID: 34592064 DOI: 10.1111/cas.15147] [Reference Citation Analysis]
4 Guo D, Zhang D, Ren M, Lu G, Zhang X, He S, Li Y. THBS4 promotes HCC progression by regulating ITGB1 via FAK/PI3K/AKT pathway. FASEB J 2020;34:10668-81. [PMID: 32567740 DOI: 10.1096/fj.202000043R] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
5 He S, Yang J, Jiang S, Li Y, Han X. Circular RNA circ_0000517 regulates hepatocellular carcinoma development via miR-326/IGF1R axis. Cancer Cell Int 2020;20:404. [PMID: 32863763 DOI: 10.1186/s12935-020-01496-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
6 Zhao Y, Wan Y, He T. Circ_SAR1A regulates the malignant behavior of lung cancer cells via the miR-21-5p/TXNIP axis. J Clin Lab Anal 2022;:e24366. [PMID: 35334496 DOI: 10.1002/jcla.24366] [Reference Citation Analysis]
7 Wang H, Zhang Q, Cui W, Li W, Zhang J. Circ_0004018 suppresses cell proliferation and migration in hepatocellular carcinoma via miR-1197/PTEN/PI3K/AKT signaling pathway. Cell Cycle 2021;20:2125-36. [PMID: 34570663 DOI: 10.1080/15384101.2021.1962633] [Reference Citation Analysis]
8 Luo Z, Lu L, Tang Q, Wei W, Chen P, Chen Y, Pu J, Wang J. CircCAMSAP1 promotes hepatocellular carcinoma progression through miR-1294/GRAMD1A pathway. J Cell Mol Med 2021;25:3793-802. [PMID: 33484498 DOI: 10.1111/jcmm.16254] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
9 Xu J, An P, Winkler CA, Yu Y. Dysregulated microRNAs in Hepatitis B Virus-Related Hepatocellular Carcinoma: Potential as Biomarkers and Therapeutic Targets. Front Oncol. 2020;10:1271. [PMID: 32850386 DOI: 10.3389/fonc.2020.01271] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
10 Wang J, Wang Y, Xu J, Song Q, Shangguan J, Xue M, Wang H, Gan J, Gao W. Global analysis of gene expression signature and diagnostic/prognostic biomarker identification of hepatocellular carcinoma. Sci Prog 2021;104:368504211029429. [PMID: 34315286 DOI: 10.1177/00368504211029429] [Reference Citation Analysis]
11 Zhang D, Zhang Y, Zhang X, Zhai H, Sun X, Li Y. Circ_0091579 Serves as a Tumor-Promoting Factor in Hepatocellular Carcinoma Through miR-1225-5p/PLCB1 Axis. Dig Dis Sci 2021. [PMID: 33559088 DOI: 10.1007/s10620-021-06861-2] [Reference Citation Analysis]
12 Ma Y, Liu Y, Jiang Z. CircRNAs: A new perspective of biomarkers in the nervous system. Biomedicine & Pharmacotherapy 2020;128:110251. [DOI: 10.1016/j.biopha.2020.110251] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
13 Jin Y, Zhang Y, Luo X. circRNA_PTPRA functions as a sponge of miR-582-3p to regulate hepatocellular carcinoma cell proliferation, migration, invasion and apoptosis. Exp Ther Med 2021;22:1276. [PMID: 34594413 DOI: 10.3892/etm.2021.10711] [Reference Citation Analysis]
14 Xu Q, Zhou L, Yang G, Meng F, Wan Y, Wang L, Zhang L. CircIL4R facilitates the tumorigenesis and inhibits ferroptosis in hepatocellular carcinoma by regulating the miR-541-3p/GPX4 axis. Cell Biol Int 2020;44:2344-56. [PMID: 32808701 DOI: 10.1002/cbin.11444] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
15 Fan W, Chen L, Wu X, Zhang T. Circ_0031242 Silencing Mitigates the Progression and Drug Resistance in DDP-Resistant Hepatoma Cells by the miR-924/POU3F2 Axis. Cancer Manag Res 2021;13:743-55. [PMID: 33531841 DOI: 10.2147/CMAR.S272851] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Ahumada A, Rayón L, Usón C, Bañares R, Alonso Lopez S. Hepatocellular carcinoma risk after viral response in hepatitis C virus-advanced fibrosis: Who to screen and for how long? World J Gastroenterol 2021; 27(40): 6737-6749 [PMID: 34790004 DOI: 10.3748/wjg.v27.i40.6737] [Reference Citation Analysis]
17 Zhu Z, Shen S, Zhao S, Wang Z. Hsa_circ_0006916 Knockdown Represses the Development of Hepatocellular Carcinoma via Modulating miR-599/SRSF2 Axis. Onco Targets Ther 2020;13:11301-13. [PMID: 33177838 DOI: 10.2147/OTT.S267471] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Bu N, Dong Z, Zhang L, Zhu W, Wei F, Zheng S. CircPVT1 Regulates Cell Proliferation, Apoptosis and Glycolysis in Hepatocellular Carcinoma via miR-377/TRIM23 Axis. Cancer Manag Res 2020;12:12945-56. [PMID: 33364841 DOI: 10.2147/CMAR.S280478] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Lyu LH, Zhang CY, Yang WJ, Jin AL, Zhu J, Wang H, Liu T, Wang BL, Cheng JW, Yang XR, Guo W. Hsa_circ_0003945 promotes progression of hepatocellular carcinoma by mediating miR-34c-5p/LGR4/β-catenin axis activity. J Cell Mol Med 2022. [PMID: 35170199 DOI: 10.1111/jcmm.17243] [Reference Citation Analysis]
20 Luo Y, Liu F, Gui R. High expression of circulating exosomal circAKT3 is associated with higher recurrence in HCC patients undergoing surgical treatment. Surg Oncol 2020;33:276-81. [PMID: 32561093 DOI: 10.1016/j.suronc.2020.04.021] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
21 Aishanjiang K, Wei XD, Fu Y, Lin X, Ma Y, Le J, Han Q, Wang X, Kong X, Gu J, Wu H. Circular RNAs and Hepatocellular Carcinoma: New Epigenetic Players With Diagnostic and Prognostic Roles. Front Oncol 2021;11:653717. [PMID: 33959506 DOI: 10.3389/fonc.2021.653717] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
22 Gao ZG, Yang P, Huang J, Ding YQ. CircFBXW7 alleviates glioma progression through regulating miR-23a-3p/PTEN axis. Anat Rec (Hoboken) 2021;304:279-90. [PMID: 32365279 DOI: 10.1002/ar.24410] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
23 Hu D, Shao W, Liu L, Wang Y, Yuan S, Liu Z, Liu J, Zhang J. Intricate crosstalk between MYB and noncoding RNAs in cancer. Cancer Cell Int 2021;21:653. [PMID: 34876130 DOI: 10.1186/s12935-021-02362-4] [Reference Citation Analysis]
24 Zhao Y, Yang B, Chen D, Zhou X, Wang M, Jiang J, Wei L, Chen Z. Combined identification of ARID1A, CSMD1, and SENP3 as effective prognostic biomarkers for hepatocellular carcinoma. Aging (Albany NY) 2021;13:4696-712. [PMID: 33558447 DOI: 10.18632/aging.202586] [Reference Citation Analysis]
25 Jiang P, Han W, Fu Y, Chen Q. The Hsa_circ_0091579/miR-940/TACR1 Axis Regulates the Development of Hepatocellular Carcinoma. Cancer Manag Res 2020;12:9087-96. [PMID: 33061603 DOI: 10.2147/CMAR.S259243] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
26 Mousavi SM, Derakhshan M, Baharloii F, Dashti F, Mirazimi SMA, Mahjoubin-Tehran M, Hosseindoost S, Goleij P, Rahimian N, Hamblin MR, Mirzaei H. Non-coding RNAs and glioblastoma: Insight into their roles in metastasis. Mol Ther Oncolytics 2022;24:262-87. [PMID: 35071748 DOI: 10.1016/j.omto.2021.12.015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
27 Song T, Li L, Wu S, Liu Y, Guo C, Wang W, Dai L, Zhang T, Wu H, Su B. Peripheral Blood Genetic Biomarkers for the Early Diagnosis of Hepatocellular Carcinoma. Front Oncol 2021;11:583714. [PMID: 33777736 DOI: 10.3389/fonc.2021.583714] [Reference Citation Analysis]
28 Liu W, Yin C, Liu Y. Circular RNA circ_0091579 Promotes Hepatocellular Carcinoma Proliferation, Migration, Invasion, and Glycolysis Through miR-490-5p/CASC3 Axis. Cancer Biother Radiopharm 2020. [PMID: 32673066 DOI: 10.1089/cbr.2019.3472] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
29 Zhao L, Ma N, Liu G, Mao N, Chen F, Li J. Lidocaine Inhibits Hepatocellular Carcinoma Development by Modulating circ_ITCH/miR-421/CPEB3 Axis. Dig Dis Sci 2021. [PMID: 33433806 DOI: 10.1007/s10620-020-06787-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
30 Chen J, Yang J, Xu Q, Wang Z, Wu J, Pan L, Huang K, Wang C. Integrated bioinformatics analysis identified MTHFD1L as a potential biomarker and correlated with immune infiltrates in hepatocellular carcinoma. Biosci Rep 2021;41:BSR20202063. [PMID: 33605411 DOI: 10.1042/BSR20202063] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Yang L, Xue H, Sun Y, Zhang L, Xue F, Ge R. CircularRNA-9119 protects hepatocellular carcinoma cells from apoptosis by intercepting miR-26a/JAK1/STAT3 signaling. Cell Death Dis 2020;11:605. [PMID: 32732872 DOI: 10.1038/s41419-020-02807-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
32 Sheng R, Li X, Wang Z, Wang X. Circular RNAs and their emerging roles as diagnostic and prognostic biomarkers in ovarian cancer. Cancer Lett 2020;473:139-47. [PMID: 31904484 DOI: 10.1016/j.canlet.2019.12.043] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
33 Manna D, Sarkar D. Non-Coding RNAs: Regulating Disease Progression and Therapy Resistance in Hepatocellular Carcinoma. Cancers (Basel) 2020;12:E1243. [PMID: 32429062 DOI: 10.3390/cancers12051243] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
34 Yang G, Zhang Y, Lin H, Liu J, Huang S, Zhong W, Peng C, Du L. CircRNA circ_0023984 promotes the progression of esophageal squamous cell carcinoma via regulating miR-134-5p/cystatin-s axis. Bioengineered 2022;13:10578-93. [PMID: 35440286 DOI: 10.1080/21655979.2022.2063562] [Reference Citation Analysis]
35 Chen G, Zhang Z, Li Y, Wang L, Liu Y. LncRNA PTPRG-AS1 Promotes the Metastasis of Hepatocellular Carcinoma by Enhancing YWHAG. J Oncol 2021;2021:3624306. [PMID: 34876904 DOI: 10.1155/2021/3624306] [Reference Citation Analysis]
36 Qin S, Mao Y, Chen X, Xiao J, Qin Y, Zhao L. The functional roles, cross-talk and clinical implications of m6A modification and circRNA in hepatocellular carcinoma. Int J Biol Sci 2021;17:3059-79. [PMID: 34421350 DOI: 10.7150/ijbs.62767] [Reference Citation Analysis]
37 Nie G, Peng D, Li B, Lu J, Cai Y, Xiong X, Cheng N. Diagnostic Accuracy of Serum/Plasma Circular RNAs and the Combination of Circular RNAs and α-Fetoprotein for Detecting Hepatocellular Carcinoma: A Meta-Analysis. Front Genet 2021;12:722208. [PMID: 34659344 DOI: 10.3389/fgene.2021.722208] [Reference Citation Analysis]
38 Xu J, Wan Z, Tang M, Lin Z, Jiang S, Ji L, Gorshkov K, Mao Q, Xia S, Cen D, Zheng J, Liang X, Cai X. N6-methyladenosine-modified CircRNA-SORE sustains sorafenib resistance in hepatocellular carcinoma by regulating β-catenin signaling. Mol Cancer 2020;19:163. [PMID: 33222692 DOI: 10.1186/s12943-020-01281-8] [Cited by in Crossref: 19] [Cited by in F6Publishing: 27] [Article Influence: 9.5] [Reference Citation Analysis]
39 Bai K, Ma Y, Li J. Circular RNA circ_0001955 promotes hepatocellular carcinoma tumorigenesis by up-regulating alkaline ceramidase 3 expression through microRNA-655-3p. Bioengineered 2022;13:2099-113. [PMID: 35034572 DOI: 10.1080/21655979.2021.2023797] [Reference Citation Analysis]
40 Gao S, Hu W, Huang X, Huang X, Chen W, Hao L, Chen Z, Wang J, Wei H. Circ_0001178 regulates miR-382/VEGFA axis to facilitate hepatocellular carcinoma progression. Cell Signal 2020;72:109621. [PMID: 32240747 DOI: 10.1016/j.cellsig.2020.109621] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
41 Zeng X, Yuan X, Cai Q, Tang C, Gao J. Circular RNA as An Epigenetic Regulator in Chronic Liver Diseases. Cells 2021;10:1945. [PMID: 34440714 DOI: 10.3390/cells10081945] [Reference Citation Analysis]
42 Gong J, Xu X, Zhang X, Zhou Y. Circular RNA-9119 suppresses in ovarian cancer cell viability via targeting the microRNA-21-5p-PTEN-Akt pathway. Aging (Albany NY) 2020;12:14314-28. [PMID: 32675386 DOI: 10.18632/aging.103470] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
43 Sun K, Zhang L, Chen P, Qi D, Liu H, Bao H, Wang X, Li T. Circular RNA circ SET domain containing 2 (circSETD2) inhibits hepatocellular carcinoma cell proliferation and invasion in vivo and in vitro. Bioengineered 2022;13:7293-302. [PMID: 35260047 DOI: 10.1080/21655979.2022.2048577] [Reference Citation Analysis]
44 Zhang B, Li F, Zhu Z, Ding A, Luo J. CircRNA CDR1as/miR-1287/Raf1 Axis Modulates Hepatocellular Carcinoma Progression Through MEK/ERK Pathway. Cancer Manag Res 2020;12:8951-64. [PMID: 33061591 DOI: 10.2147/CMAR.S252679] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
45 Shang W, Adzika GK, Li Y, Huang Q, Ding N, Chinembiri B, Rashid MS, Machuki JO. Molecular mechanisms of circular RNAs, transforming growth factor-β, and long noncoding RNAs in hepatocellular carcinoma. Cancer Med 2019;8:6684-99. [PMID: 31523930 DOI: 10.1002/cam4.2553] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
46 Liao R, Liu L, Zhou J, Wei X, Huang P. Current Molecular Biology and Therapeutic Strategy Status and Prospects for circRNAs in HBV-Associated Hepatocellular Carcinoma. Front Oncol 2021;11:697747. [PMID: 34277444 DOI: 10.3389/fonc.2021.697747] [Reference Citation Analysis]
47 Bin X, Chen Y, Ma J, Tang R, Zhao Z, Wang K, Wang J. circ_0001588 Induces the Malignant Progression of Hepatocellular Carcinoma by Modulating miR-874/CDK4 Signaling. J Immunol Res 2021;2021:3759879. [PMID: 34722778 DOI: 10.1155/2021/3759879] [Reference Citation Analysis]
48 Zhang Y, Wang D, Zhu T, Yu J, Wu X, Lin W, Zhu M, Dai Y, Zhu J. CircPUM1 promotes hepatocellular carcinoma progression through the miR-1208/MAP3K2 axis. J Cell Mol Med 2021;25:600-12. [PMID: 33320435 DOI: 10.1111/jcmm.15998] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]